Comparison of Individually Tailored Vs Systematic Rituximab Regimens to Maintain ANCA-Associated Vasculitis Remissions: Results of a Prospective, Randomized-Controlled, Phase 3 Trial - Aix-Marseille Université Access content directly
Conference Papers Year : 2017

Comparison of Individually Tailored Vs Systematic Rituximab Regimens to Maintain ANCA-Associated Vasculitis Remissions: Results of a Prospective, Randomized-Controlled, Phase 3 Trial

Pierre Charles
  • Function : Author
Christian Agard
  • Function : Author
  • PersonId : 908815
Noemie Jourde-Chiche
  • Function : Author
  • PersonId : 1064169
Francois Lifermann
  • Function : Author
  • PersonId : 955440
N.M. Silva
  • Function : Author
Xavier Puéchal
  • Function : Author
  • PersonId : 953182
Luc Mouthon
  • Function : Author
  • PersonId : 904972
Fichier principal
Vignette du fichier
Charles, Terrier, Perrodeau, Cohen...Comparison of Individually Tailored Vs Systematic Rituximab Regimens to Maintain ANCA.pdf (190.59 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01787131 , version 1 (25-05-2018)

Identifiers

  • HAL Id : hal-01787131 , version 1

Cite

Pierre Charles, Benjamin Terrier, Elodie Perrodeau, Pascal Cohen, Stanislas Faguer, et al.. Comparison of Individually Tailored Vs Systematic Rituximab Regimens to Maintain ANCA-Associated Vasculitis Remissions: Results of a Prospective, Randomized-Controlled, Phase 3 Trial. 2017 ACR.ARHP ANNUAL MEETING, Nov 2017, SAN DIEGO, United States. ⟨hal-01787131⟩
129 View
103 Download

Share

Gmail Facebook X LinkedIn More